|Description||Clopidogrel, a thienopyridine derivative, could be used in the prevention and treatment of sorts of arterial circulation disorders caused by platelet aggregation.|
|Synonyms||Clopidogrel; Plavix; Zyllt; (S)-Clopidogrel; CLOPIDOGREL SULFATE|
|Solubility||10 mM in DMSO|
|Application||Clopidogrel could be used in the prevention and treatment of sorts of arterial circulation disorders caused by platelet aggregation.|
|Shelf Life||As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly|
|Boiling Point||423.7ºC at 760mmHg|
BPTU is an allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM) that binds receptors outside of the helical bundle. BPTU blocks inhibition of spontaneous contract...
N6-(4-Hydroxybenzyl)adenosine, an imidazopyrimidine derivative, could be effective as an inhibitor of platelet aggregation. IC50: 6.77-141 μM.
NF 546 is a P2Y11 agonist with pEC50 value of 6.27. It can stimulate release of interleukin-8 from human monocyte-derived dendritic cells.
AR-C126313, a thiouracil derivative, has been found to be a competitive P2Y2 receptor antagonist and could inhibit P2Y2 receptor-induced β-arrestin translocatio...
Prasugrel Maleic acid
Prasugrel is a platelet inhibitor (IC50=1.8 μM) , as a third-generation thienopyridine.
Clopidogrel, a thienopyridine derivative, could be used in the prevention and treatment of sorts of arterial circulation disorders caused by platelet aggregatio...
Clopidogrel is converted to its active metabolite by cytochrome P450 (CYP) enzymes.
The thiolactone form of Clopidogrel that could be an effective antiplatelet agent for behaving as an inhibitor of P2Y12 receptor.